調査レポートカテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

Global Gastro Esophageal Reflux Disease (GERD) Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

世界の胃食道逆流症（GERD）薬市場2020：企業別・地域別・種類別・用途別市場予測（~2025）

◆タイトル：Global Gastro Esophageal Reflux Disease (GERD) Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード：GIR20MY06849
◆調査・発行会社：Global Info Research
◆発行日：2020年5月
◆ページ数：107
◆レポート形式：（印刷可能）PDF / 英語
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療・製薬
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥375,840	見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）	USD5,220 ⇒換算￥563,760	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥751,680	見積依頼/購入/質問フォーム

※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常2日～3日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobal Info Researchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、胃食道逆流症（GERD）薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。胃食道逆流症（GERD）薬の種類別市場規模（H2受容体拮抗薬、プロトンポンプ阻害剤（PPi）、制酸剤）、用途別市場規模（病院、クリニック、医療センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Merck、Novartis AG、GlaxoSmithKline、Medtronic
・地域別グローバル市場分析 2015年-2020年
・胃食道逆流症（GERD）薬の北米市場（アメリカ、カナダ、メキシコ）
・胃食道逆流症（GERD）薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア）
・胃食道逆流症（GERD）薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア）
・胃食道逆流症（GERD）薬の南米市場（ブラジル、アルゼンチン）
・胃食道逆流症（GERD）薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ）
・種類別分析：H2受容体拮抗薬、プロトンポンプ阻害剤（PPi）、制酸剤
・用途別分析：病院、クリニック、医療センター、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Gastro Esophageal Reflux Disease (GERD) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Gastro Esophageal Reflux Disease (GERD) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Gastro Esophageal Reflux Disease (GERD) Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Gastro Esophageal Reflux Disease (GERD) Drug market has been segmented into
H2 Receptor Antagonist
Proton Pump Inhibitor (PPi)
Antacids

By Application, Gastro Esophageal Reflux Disease (GERD) Drug has been segmented into:
Hospital
Clinic
Medical Center
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gastro Esophageal Reflux Disease (GERD) Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Gastro Esophageal Reflux Disease (GERD) Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gastro Esophageal Reflux Disease (GERD) Drug market.

The report offers in-depth assessment of the growth and other aspects of the Gastro Esophageal Reflux Disease (GERD) Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Gastro Esophageal Reflux Disease (GERD) Drug Market Share Analysis
Gastro Esophageal Reflux Disease (GERD) Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gastro Esophageal Reflux Disease (GERD) Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gastro Esophageal Reflux Disease (GERD) Drug sales, revenue and market share for each player covered in this report.

The major players covered in Gastro Esophageal Reflux Disease (GERD) Drug are:
Pfizer
Merck
Novartis AG
GlaxoSmithKline
Medtronic

Among other players domestic and global, Gastro Esophageal Reflux Disease (GERD) Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastro Esophageal Reflux Disease (GERD) Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug, with price, sales, revenue and global market share of Gastro Esophageal Reflux Disease (GERD) Drug in 2018 and 2019.
Chapter 3, the Gastro Esophageal Reflux Disease (GERD) Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastro Esophageal Reflux Disease (GERD) Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Gastro Esophageal Reflux Disease (GERD) Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Gastro Esophageal Reflux Disease (GERD) Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Gastro Esophageal Reflux Disease (GERD) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 H2 Receptor Antagonist
1.2.3 Proton Pump Inhibitor (PPi)
1.2.4 Antacids
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Center
1.3.5 Others
1.4 Overview of Global Gastro Esophageal Reflux Disease (GERD) Drug Market
1.4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis AG SWOT Analysis
2.3.4 Novartis AG Product and Services
2.3.5 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline SWOT Analysis
2.4.4 GlaxoSmithKline Product and Services
2.4.5 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Medtronic
2.5.1 Medtronic Details
2.5.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Medtronic SWOT Analysis
2.5.4 Medtronic Product and Services
2.5.5 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gastro Esophageal Reflux Disease (GERD) Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Gastro Esophageal Reflux Disease (GERD) Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
4.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
4.5 South America Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Market Share by Country
5.1.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
5.3 Canada Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
6.3 UK Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
6.4 France Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
6.5 Russia Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
6.6 Italy Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
7.3 Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
7.4 Korea Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
7.5 India Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
7.7 Australia Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Market Share by Country
8.1.1 South America Gastro Esophageal Reflux Disease (GERD) Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales and Market Share by Type (2015-2020)
10.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2015-2020)
11 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Segment by Application
11.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2015-2020)
11.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2015-2020)
11.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast (2021-2025)
12.2.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast (2021-2025)
12.2.4 South America Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast (2021-2025)
12.3 Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast by Type (2021-2025)
12.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share Forecast by Type (2021-2025)
12.4 Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast by Application (2021-2025)
12.4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gastro Esophageal Reflux Disease (GERD) Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Major Business
Table 9. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Total Revenue (USD Million) (2018-2019)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product and Services
Table 12. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Gastro Esophageal Reflux Disease (GERD) Drug Major Business
Table 15. Merck Gastro Esophageal Reflux Disease (GERD) Drug Total Revenue (USD Million) (2018-2019)
Table 16. Merck SWOT Analysis
Table 17. Merck Gastro Esophageal Reflux Disease (GERD) Drug Product and Services
Table 18. Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 20. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Major Business
Table 21. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Total Revenue (USD Million) (2018-2019)
Table 22. Novartis AG SWOT Analysis
Table 23. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product and Services
Table 24. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 26. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Major Business
Table 27. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Total Revenue (USD Million) (2018-2019)
Table 28. GlaxoSmithKline SWOT Analysis
Table 29. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product and Services
Table 30. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Medtronic Basic Information, Manufacturing Base and Competitors
Table 32. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Major Business
Table 33. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Total Revenue (USD Million) (2018-2019)
Table 34. Medtronic SWOT Analysis
Table 35. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product and Services
Table 36. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 38. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Regions (2015-2020) (K Pcs)
Table 40. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Regions (2015-2020)
Table 41. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Countries (2015-2020) (K Pcs)
Table 43. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Countries (2015-2020)
Table 44. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Countries (2015-2020)
Table 46. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Countries (2015-2020) (K Pcs)
Table 47. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Countries (2015-2020)
Table 48. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Regions (2015-2020) (K Pcs)
Table 50. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Countries (2015-2020) (K Pcs)
Table 53. South America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Countries (2015-2020)
Table 54. South America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Countries (2015-2020) (K Pcs)
Table 57. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Countries (2015-2020)
Table 60. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Type (2015-2020)
Table 62. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2015-2020) (USD Million)
Table 63. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Type (2015-2020)
Table 64. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2015-2020) (K Pcs)
Table 65. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Application (2015-2020)
Table 66. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 67. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share Forecast by Regions (2021-2025)
Table 68. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 69. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share Forecast by Type (2021-2025)
Table 70. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Application (2021-2025)
Table 71. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Gastro Esophageal Reflux Disease (GERD) Drug Picture
Figure 2. Global Sales Market Share of Gastro Esophageal Reflux Disease (GERD) Drug by Type in 2019
Figure 3. H2 Receptor Antagonist Picture
Figure 4. Proton Pump Inhibitor (PPi) Picture
Figure 5. Antacids Picture
Figure 6. Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application in 2018
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Medical Center Picture
Figure 10. Others Picture
Figure 11. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Gastro Esophageal Reflux Disease (GERD) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Manufacturer in 2019
Figure 32. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Gastro Esophageal Reflux Disease (GERD) Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Gastro Esophageal Reflux Disease (GERD) Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 37. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Regions (2015-2020)
Figure 39. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Regions in 2018
Figure 40. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
Figure 41. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
Figure 43. South America Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020)
Figure 45. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Countries (2015-2020)
Figure 47. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Countries in 2018
Figure 48. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Countries in 2018
Figure 50. United States Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Canada Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Mexico Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Countries in 2019
Figure 56. Germany Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. UK Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. France Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Russia Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Regions 2019
Figure 64. China Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Korea Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. India Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. South America Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Countries in 2019
Figure 71. South America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Countries in 2019
Figure 72. Brazil Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Argentina Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Egypt Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Turkey Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. South Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 83. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast (2021-2025) (K Pcs)
Figure 85. Europe Sales Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast (2021-2025) (K Pcs)
Figure 86. Asia-Pacific Sales Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. South America Sales Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. Middle East & Africa Sales Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の胃食道逆流症（GERD）薬市場2020：企業別・地域別・種類別・用途別市場予測（~2025）] (Global Gastro Esophageal Reflux Disease (GERD) Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / GIR20MY06849)についてメールでお問い合わせはこちら

◆関連調査資料◆

世界の胃食道逆流症（GERD）治療市場2020：企業別・地域別・種類別・用途別市場予測（~2025）
GIR20MY06851 / GlobalInfoResearch / 2020年5月 / 本調査レポートでは、胃食道逆流症（GERD）治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。胃食道逆流症（GERD）治療の種類別市場規模（制酸剤、運動促進剤、H2受容体遮断薬、プロトンポンプ阻害剤（PPI））、用途別市場規模（胸焼け、酸逆流症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。・市場概要・企業情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca、Takeda、Eisai、GSK、Johnson & Johnson ・地域別グローバル市場分析 2015年-2020年・胃食道逆流症（GERD）治療の北米市場（アメリカ、カナダ、メキシコ）・胃食道逆流症（GERD）治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア）・胃食道逆流症（GERD）治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア）...Market Overview The global Gastroesophageal Reflux Disease (GERD) Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.6% in the forecast period of 2020 to 2025 and will expected to reach USD 4989.6 million by 2025, from USD 4870.2 million in 2019. The Gastroesophageal Reflux Disease (GERD) Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis,...

胃食道逆流症（GERD）デバイスの世界市場2019：企業別、地域別、種類別、用途別
GIR9090279 / GlobalInfoResearch / 2019年9月 / 本調査レポートは、胃食道逆流症（GERD）デバイスの世界市場について調べ、まとめました。種類別セグメントは、診断機器、治療機器等、用途別セグメントは、病院、クリニック、外来手術センター等に区分しました。胃食道逆流症（GERD）デバイスの世界市場概観、企業動向、企業別胃食道逆流症（GERD）デバイスシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。・胃食道逆流症（GERD）デバイスの市場概観・胃食道逆流症（GERD）デバイスの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）・胃食道逆流症（GERD）デバイスの企業別販売動向、市場シェア、市場集中度、競争動向・胃食道逆流症（GERD）デバイスの世界市場規模・胃食道逆流症（GERD）デバイスの北米市場分析（アメリカ、カナダ、メキシコ等）・胃食道逆流症（GERD）デバイスのアメリカ市場規模推移・胃食道逆流症（GERD）デバイスのカナダ市場規模推移・胃食道逆流症（GERD）デバイスのメキシコ市場規模推移・胃食道逆流症（GERD）デバイスのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Gastroesophageal reflux disease (GERD), also known as acid reflux, is a long-term condition in which stomach contents rise up into the esophagus, resulting in either symptoms or complications. Symptoms include the taste of acid in the back of the mouth, heartburn, bad breath, chest pain, vomiting, breathing problems, and wearing away of the teeth. Complications include esophagitis, esophageal stricture, and Barrett's esophagus. Scope of the Report: The global Gastroesophageal Reflux Disease (GERD) Devices market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of...

世界の深部静脈血栓症（DVT）薬市場2020：企業別・地域別・種類別・用途別市場予測（~2025）
GIR20MY04148 / GlobalInfoResearch / 2020年5月 / 本調査レポートでは、深部静脈血栓症（DVT）薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。深部静脈血栓症（DVT）薬の種類別市場規模（抗凝血剤、組織プラスミノーゲン活性剤、その他の薬剤）、用途別市場規模（病院、クリニック、ドラッグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。・市場概要・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer、Sanofi、Bristol-Myers Squibb、Pfizer、Daiichi Sankyo、GSK ・地域別グローバル市場分析 2015年-2020年・深部静脈血栓症（DVT）薬の北米市場（アメリカ、カナダ、メキシコ）・深部静脈血栓症（DVT）薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア）・深部静脈血栓症（DVT）薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア）...Market Overview The global Deep Vein Thrombosis (DVT) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Deep Vein Thrombosis (DVT) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis,...

世界の注意欠陥多動性障害（ADHD）薬市場2020：企業別・地域別・種類別・用途別市場予測（~2025）
GIR20MY01057 / GlobalInfoResearch / 2020年5月 / 本調査レポートでは、注意欠陥多動性障害（ADHD）薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。注意欠陥多動性障害（ADHD）薬の種類別市場規模（覚せい剤、非覚せい剤）、用途別市場規模（小児科、青年期、成人）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。・市場概要・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Eli Lilly、Celltech Group、Janssen Pharmaceuticals, Inc.、Perdue Pharma、Novartis、Johnson & Johnson、Glaxosmith...Market Overview The global Attention Deficit Hyperactivity Disorder (ADHD) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Attention Deficit Hyperactivity Disorder (ADHD) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments,...

世界のヒトヘルペスウイルス5型（HHV-5）薬市場2020：企業別・地域別・種類別・用途別市場予測（~2025）
GIR20MY07898 / GlobalInfoResearch / 2020年5月 / 本調査レポートでは、ヒトヘルペスウイルス5型（HHV-5）薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。ヒトヘルペスウイルス5型（HHV-5）薬の種類別市場規模（ガンシクロビル、バレリアンギリビル薬、アシクロビル薬、バラシクロビル薬、ホスカルネットナトリウム薬）、用途別市場規模（免疫不全群、臓器移植群、CMVヘルペス群）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。・市場概要・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Haikou Kellett、Hubei Branch benefits medicine、Livzon Pharmaceuticals、Chongqing Winbond (acquisition...Market Overview The global Human Herpersvirus 5 (HHV-5) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Herpersvirus 5 (HHV-5) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis,...

世界の骨髄異形成症候群（MDS）薬市場2020：企業別・地域別・種類別・用途別市場予測（~2025）
GIR20MY10866 / GlobalInfoResearch / 2020年5月 / 本調査レポートでは、骨髄異形成症候群（MDS）薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。骨髄異形成症候群（MDS）薬の種類別市場規模（低メチル化剤、免疫調節薬、抗貧血薬）、用途別市場規模（オリジナル、ジェネリック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。・市場概要・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Celgene、Takeda、Amgen、Otsuka ・地域別グローバル市場分析 2015年-2020年・骨髄異形成症候群（MDS）薬の北米市場（アメリカ、カナダ、メキシコ）・骨髄異形成症候群（MDS）薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア）・骨髄異形成症候群（MDS）薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア）・骨髄異形成症候群（MDS）薬の南米市場（ブラジル、アルゼンチン）・骨髄異形成症候群（MDS）薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ）...Market Overview The global Myelodysplastic Syndrome (MDS) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1798.3 million by 2025, from USD 1452.7 million in 2019. The Myelodysplastic Syndrome (MDS) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market...

世界の関節リウマチ（RA）薬市場2020：企業別・地域別・種類別・用途別市場予測（~2025）
GIR20MY13475 / GlobalInfoResearch / 2020年5月 / 本調査レポートでは、関節リウマチ（RA）薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。関節リウマチ（RA）薬の種類別市場規模（経口、注射、外用）、用途別市場規模（医療、パーソナルケア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。・市場概要・企業情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie、UCB、Amgen, Inc.、Roche、Bristol-Myers Squibb、Johnson & Johnson、Sanofi、Merck、Pfizer、GlaxoSmithKline、Abbott Laboratories、Teva Pharmaceutical ・地域別グローバル市場分析...Market Overview The global Rheumatoid Arthritis (RA) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.4% in the forecast period of 2020 to 2025 and will expected to reach USD 21300 million by 2025, from USD 18600 million in 2019. The Rheumatoid Arthritis (RA) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market...

世界のエリスロポエチン（EPO）薬市場2020：企業別・地域別・種類別・用途別市場予測（~2025）
GIR20MY05588 / GlobalInfoResearch / 2020年5月 / 本調査レポートでは、エリスロポエチン（EPO）薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。エリスロポエチン（EPO）薬の種類別市場規模（エポエチンアルファ、ダルベポエチンアルファ、エポエチンベータ、その他）、用途別市場規模（貧血、腎障害、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。・市場概要・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Amgen、Biocon、Galenica、Johnson & Johnson、3SBio、Roche、Kyowa Hakko Kirin、Emcure、LG Life Sciences ・地域別グローバル市場分析...Market Overview The global Erythropoietin (EPO) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 10830 million by 2025, from USD 8727.6 million in 2019. The Erythropoietin (EPO) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis,...

世界の下痢を伴う過敏性腸症候群（IBS-D）薬市場2020：企業別・地域別・種類別・用途別市場予測（~2025）
GIR20MY08717 / GlobalInfoResearch / 2020年5月 / 本調査レポートでは、下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。下痢を伴う過敏性腸症候群（IBS-D）薬の種類別市場規模（エルキサドリン、アロセトロン、リファキシミン、ロペラミド、ジフェノキシレート+アトロピン、ジシクロミン＆ヒヨスチアミン）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。・市場概要・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Astellas Pharmaceuticals、GlaxoSmithKline、Actavis、Pfizer、AstraZenenca、Salix Pharmaceuticals Ltd ・地域別グローバル市場分析 2015年-2020年・下痢を伴う過敏性腸症候群（IBS-D）薬の北米市場（アメリカ、カナダ、メキシコ）・下痢を伴う過敏性腸症候群（IBS-D）薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア）...Market Overview The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,...

世界の黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬市場2020：企業別・地域別・種類別・用途別市場予測（~2025）
GIR20MY09606 / GlobalInfoResearch / 2020年5月 / 本調査レポートでは、黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の種類別市場規模（黄斑変性薬、糖尿病性網膜症薬）、用途別市場規模（50〜60歳、60〜70歳、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。・市場概要・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Neurotech Pharmaceuticals、Bayer Healthcare、Roche、Allergan、Regeneron Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年・黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の北米市場（アメリカ、カナダ、メキシコ）・黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア）...Market Overview The global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆